Astec Lifesciences (NSE:ASTEC) EV-to-Revenue : 5.76 (As of Jun. 03, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Astec Lifesciences's enterprise value is ₹26,384 Mil. Astec Lifesciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹4,582 Mil. Therefore, Astec Lifesciences's EV-to-Revenue for today is 5.76.

The historical rank and industry rank for Astec Lifesciences's EV-to-Revenue or its related term are showing as below:

NSE:ASTEC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.15 Med: 3.43 Max: 6.59
Current: 5.76

During the past 13 years, the highest EV-to-Revenue of Astec Lifesciences was 6.59. The lowest was 0.15. And the median was 3.43.

NSE:ASTEC's EV-to-Revenue is ranked worse than
88.48% of 243 companies
in the Agriculture industry
Industry Median: 1.24 vs NSE:ASTEC: 5.76

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-03), Astec Lifesciences's stock price is ₹1095.80. Astec Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹233.62. Therefore, Astec Lifesciences's PS Ratio for today is 4.69.

Astec Lifesciences EV-to-Revenue Historical Data

The historical data trend for Astec Lifesciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences EV-to-Revenue Chart

Astec Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

1.64

3.88

5.49

4.87

5.64

Astec Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															4.87	4.44	6.07	4.98	5.64

Competitive Comparison of Astec Lifesciences's EV-to-Revenue

For the Agricultural Inputs subindustry, Astec Lifesciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences's EV-to-Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's EV-to-Revenue falls into.

Astec Lifesciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Astec Lifesciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	26383.939	/	4581.808
	=	5.76

Astec Lifesciences's current Enterprise Value is ₹26,384 Mil.
Astec Lifesciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,582 Mil.

Astec Lifesciences (NSE:ASTEC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Astec Lifesciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1095.80	/	233.624
	=	4.69

Astec Lifesciences's share price for today is ₹1095.80.
Astec Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹233.62.

Astec Lifesciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences (NSE:ASTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (NSE:ASTEC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

533138:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.astecls.com

Astec Lifesciences Ltd is engaged in producing agrochemicals and pharmaceutical intermediates. The company's products include agrochemicals, such as Tebuconazole, Propiconazole, Hexaconazole, Difenoconazole, Epoxiconazole, Cyproconazole, Flutriafol, Tricyclazole, Metalaxyl and lambda-cyhalothrin, and intermediates. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences (NSE:ASTEC) Headlines

No Headlines